Page de couverture de Essentials of CRISPR-based Animal Models in Drug Discovery

Essentials of CRISPR-based Animal Models in Drug Discovery

Essentials of CRISPR-based Animal Models in Drug Discovery

Auteur(s): The CRISPR Journal
Écouter gratuitement

À propos de cet audio

In this podcast miniseries, learn about the scientific, technological and logistical aspects of using CRISPR to generate animal models in drug development. Hosted by The CRISPR Journal’s Executive Editor Kevin Davies, the series features experts from Taconic discussing key issues in using CRISPR to produce precision gene edits, including considerations around licensing and intellectual property.




See acast.com/privacy for privacy and opt-out information.

Mary Ann Liebert, Inc.
Science
Épisodes
  • Choosing the Best Genetic Modification Technology to Generate an Animal Model
    Nov 5 2020
    Evert-Jan Uringa and Dominique Bröehl, Scientific Program Managers with Taconic, discuss how to choose the best genetic modification technology to generate an animal model.

    See acast.com/privacy for privacy and opt-out information.

    Voir plus Voir moins
    20 min
  • Legal Considerations When Choosing a Genetic Modification Technology to Generate an Animal Model
    Dec 2 2020
    Gretchen Rice, PhD, JD, Vice President and General Counsel, and Mark Johnson, PhD, Scientific Program Manager, discuss the licensing considerations that go into using CRISPR and other gene editing platforms to create genetically engineered animal models.

    See acast.com/privacy for privacy and opt-out information.

    Voir plus Voir moins
    18 min
  • What is so different about CRISPR Founder breeding?
    Dec 16 2020
    Gretchen Kusek, PhD, Associate Director Scientific Services, and Bart Smits, PhD, Manager Genetic Sciences and Compliance, discuss the key considerations when breeding gene-edited animals using CRISPR, particularly in the context of mosaicism.

    See acast.com/privacy for privacy and opt-out information.

    Voir plus Voir moins
    29 min
Pas encore de commentaire